You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Pharmacists' Report

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

October 2, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Pertuzumab ups survival in HER2-positive metastatic breast cancer

Patients with HER2-positive metastatic breast cancer who received pertuzumab as part of their chemotherapy regimen had a significantly longer median survival rate. » More

ADVERTISEMENT

Certificate Program: MTM for Patients with Diabetes Oct. 18
Don't miss the chance to earn up to 13 CPE credits through this 7-hour innovative live program and MTM encounters presented by the UConn School of Pharmacy and Drug Topics. For more information. Click Here

Wisconsin college planning pharmacy school

The Medical College of Wisconsin is planning a feasibility study to examine whether it should open a new pharmacy school in either Green Bay or elsewhere in the state. » More

Are pharmacists pill-happy?

Pharmacist Dennis Miller asks: Have pharmacists uncritically accepted the pill-for-every-ill mentality? » More

ADVERTISEMENT

New Oral Anti-Coagulants
Article, video, tools and CME on emerging oral anticoagulant therapies to assist you in meeting the healthcare challenges associated with nonvalvular atrial fibrillation. Learn More.

Two HIV-1 cocktail drugs approved

The new drugs are elvitegravir, an integrase inhibitor, and cobicistat, a protease-inhibitor booster. » More

Continuing Education

MTM essentials for anticoagulant management in cardiovascular disease

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacological properties, safety and efficacy, and risk/benefit profile for the various anticoagulant medications used in cardiovascular diseases.

To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT10-VXP89.

Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/.

LIVE SPECIAL EVENT: Medication Management for Patients with Diabetes CPE Series

 

Check these out, too

Asthma drug label includes CVD risks

No increased risk of suicide with Chantix

California techs get expanded duties

Tiotropium bromide mist for COPD approved

Voices

Anticoagulation Update

JP at Large

View from the Zoo

Viewpoints

Regulatory and Legal

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group